Success Stories: EB1B Approval for a Research Scientist in the field of Pharmacology in only 1 day

Posted by wegreened on August 13, 2013 in EB1 Green Card, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonials:

Thank you for all your professional and efficient works on my case. I’ll be more than happy to recommend you to my friends who are looking for Immigration Attorney.

On August 6th, 2013, we received another EB1B Approval for a Research Scientist in the field of Pharmacology (Approval Notice)

General Field: Pharmacology
Position at the Time of Case Filing: Research Scientist
Petitioner: A Private Medical School
National Origin: China
Service Center: Nebraska Service Center (NSC)
State Residing at the Time of Filing: Wisconsin
Approval Notice Date: August 6, 2013
Processing Time: 1 day (Premium Processing Service requested)

Case Summary:

At North America Immigration Law Group – WeGreened.com, we recently received an EB1B approval for a research scientist in the field of pharmacology. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. His work had focused on the primary factors leading to cancer induction and growth at the molecular level, with an additional focus on mitochondria-derived oxidizing species; how to take advantage of and exacerbate the anticancer properties of cholesterol-lowering drugs/statins in breast cancer therapy; and how to utilize a molecular breaker in the battle against diabetic complications and aging. His research work had resulted in at least 13 peer-reviewed scholarly articles accepted or published in leading international journals, international conference proceedings (1 paper) and 12 international/national conference abstracts and presentations, along with 6 published patents. Furthermore, the beneficiary had a total of 77 citations by researchers around the world for his publications before filing the petition. In addition, he had been invited to review 32 times for scholarly articles, manuscripts, and abstracts submitted by worldwide researchers/scientists to prestigious journals and conferences. The petitioner in this case was a private medical school. Our beneficiary’s outstanding expertise is summarized in a quote by an independent recommender, “[The beneficiary’s] groundbreaking findings demonstrate that mitochondria-targeted nitroxides are novel inhibitors of breast cancer cell survival and proliferation, and may be useful in potentiating the cytostatic and cytotoxic effects of other chemotherapeutic agents.” It was our goal to prove that this beneficiary qualifies for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. His petition was swiftly approved in just 1 day.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%